IGF-IIR Antibodies

Santa Cruz Biotechnology provides a broad selection of IGF-IIR monoclonal antibodies for research focused on understanding the insulin-like growth factor signaling pathway. IGF-IIR monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The insulin-like growth factor II receptor (IGF-IIR) plays a crucial role in regulating cellular growth and development by modulating the availability of insulin-like growth factors. IGF-IIR is involved in essential physiological processes, including fetal development and tissue repair, and has implications in various diseases, including cancer and metabolic disorders. Understanding IGF-IIR function is vital for elucidating its role in cellular signaling and development. IGF-IIR research continues to reveal new insights into growth factor regulation and cellular metabolism. Investigating IGF-IIR expression patterns helps identify potential therapeutic targets for various medical conditions. Current research highlights IGF-IIR's significance in developmental biology and disease progression. Santa Cruz Biotechnology monoclonal antibodies for IGF-IIR enable researchers worldwide to advance scientific understanding of growth factor signaling pathways and their impact on human health.